AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 100 filers reported holding AVROBIO INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $22,000 | -70.7% | 16,541 | -15.2% | 0.00% | – |
| Q4 2021 | $75,000 | -72.4% | 19,503 | -60.0% | 0.00% | – |
| Q3 2021 | $272,000 | -38.7% | 48,741 | -2.5% | 0.00% | -100.0% |
| Q2 2021 | $444,000 | -34.7% | 49,978 | -6.8% | 0.00% | 0.0% |
| Q1 2021 | $680,000 | +3.3% | 53,597 | +13.6% | 0.00% | 0.0% |
| Q4 2020 | $658,000 | +7.2% | 47,179 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $614,000 | -24.5% | 47,179 | +1.3% | 0.00% | 0.0% |
| Q2 2020 | $813,000 | +46.8% | 46,577 | +30.7% | 0.00% | 0.0% |
| Q1 2020 | $554,000 | -14.2% | 35,627 | +10.9% | 0.00% | 0.0% |
| Q4 2019 | $646,000 | +42.6% | 32,111 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $453,000 | +15.3% | 32,111 | +33.0% | 0.00% | 0.0% |
| Q2 2019 | $393,000 | -9.7% | 24,147 | +22.5% | 0.00% | 0.0% |
| Q1 2019 | $435,000 | +184.3% | 19,706 | +114.1% | 0.00% | – |
| Q4 2018 | $153,000 | -68.0% | 9,206 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $478,000 | – | 9,206 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 4,001,627 | $6,162,506 | 5.66% |
| Vazirani Asset Management LLC | 468,273 | $721,140 | 1.10% |
| Atlas Venture Life Science Advisors, LLC | 4,541,381 | $6,993,727 | 1.08% |
| Terrapin Asset Management, LLC | 558,787 | $860,532 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 3,512,686 | $5,409,536 | 0.76% |
| Newtyn Management, LLC | 2,000,000 | $3,080,000 | 0.76% |
| Aldebaran Capital, LLC | 470,130 | $724,000 | 0.74% |
| Aisling Capital Management LP | 1,009,779 | $1,555,060 | 0.64% |
| Western Standard LLC | 310,361 | $477,956 | 0.43% |
| Affinity Asset Advisors, LLC | 500,000 | $770,000 | 0.22% |